Growth response and levels of growth factors after two years growth hormone treatment are similar for a once and twice daily injection regimen in girls with Turner syndrome

Clinical Endocrinology

Volumn 46, Issue 4, 1997, Pages 451-459

  Van Teunenbroek, A ^a   De Muinck Keizer Schrama, S ^a   Stijnen, T ^b   Waelkens, J ^c   Wit, J M ^d   Vulsma, T ^e   Gerver, W J ^f   Reeser, H ^g   Delemarre van De Waal, H ^h   Jansen, M ⁱ   Drop, S ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c CATHARINA HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^g JULIANA CHILDREN S HOSPITAL   (Netherlands)

^h VU UNIVERSITY MEDICAL CENTER   (Netherlands)

ⁱ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ETHINYLESTRADIOL; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; HUMAN GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; BODY GROWTH; BODY HEIGHT; BONE AGE; BONE MATURATION; CHILD; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; FEMALE; HUMAN; INJECTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PUBERTY; RADIOIMMUNOASSAY; SUBCUTANEOUS DRUG ADMINISTRATION; TURNER SYNDROME;

EID: 8244259924     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.1610972.x     Document Type: Article

References (40)

1. Albertsson-Wikland, K. & Rosberg, S. (1988) Analyses of 24-growth hormone profiles in children: relation to growth. Journal of Clinical Endocrinology Metabolism, 67, 493-500.
2. Bayley, N.B. & Pinneau, S.R. (1952) Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. Journal of Pediatrics, 40, 423-441.
3. Blum, W.F., Ranke, M.B., Kietzmann, K., Gauggel, E., Zeisel, H.J. & Bierich, J.R. (1990) A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. Journal of Clinical Endocrinology Metabolism, 70, 1292-1298.
4. Cameron, N. (1978) The methods of auxological anthropometry. In Human Growth (eds F. Falkner & J.M. Tanner), Tindall, London, pp 35-90.
5. Carlsson, L.M.S. & Albertsson-Wikland, K. (1993) Growth hormone-binding protein concentration in girls with Turner syndrome: Effects of GH, oxandrolone and ethinyl estradiol. In Basic and clinical approach to Turner syndrome (eds I. Hibi & K. Takano), pp. 255-260. Elsevier Science Publishers B.V., Amsterdam.
6. Carlsson, L.M.S., Attie, K.M., Compton, P.G., Vitangcol, R.V. & Merimee, T.J. (1994) Reduced concentration of serum growth hormone-binding protein in children with idiopathic short stature. Journal of Clinical Endocrinology Metabolism, 78, 1325-1330.
7. Carlsson, L.M.S., Rowland, A.M., Clark, R.G., Gesundheit, N. & Wong, W.L.T. (1991) Ligand-mediated immunofunctional assay for quantitation of growth hormone-binding protein in human blood. Journal of Clinical Endocrinology Metabolism, 73, 1216-1223.
8. Clark, R. G., Jansson, J.O., Isaksson, O. & Robinson, I.C.A.F. (1985) Intravenous growth hormone: growth responses to patterned infusions in hypophysectiomized rats. Journal of Endocrinology, 104, 53-61.
9. De Schepper, J., Craen, M., Massa, G., Heinrichs, C., Maes, M., Caju, M., Rausin, L. & Bourguignon, J.-P. (1994) Growth hormone therapy in Turner's syndrome: one versus two daily injections. Journal of Clinical Endocrinology Metabolism, 79, 489-494.
10. Greulich, W.W. & Pyle, S.J. (1959) Radiographic atlas of skeletal development of the hand and wrist. Stanford University Press, California.
11. Hindmarsh, P.C., Matthews, D.R., Stratton, I., Pringle, P.J. & Brook, C.G.D. (1992) Rate of change (modulation) of serum growth hormone concentrations is a more important factor in determining growth rate than duration of exposure. Clinical Endocrinology, 36, 165-170.
12. Hokken-Koelega, A.C.S., Hackeng, W.H.L., Stijnen, T., Wit, J.M., de Muinck Keizer-Schrama, S.M.P.F. & Drop, S.L.S. (1990) 24-Hour plasma GH profiles, urinary GH excretion and plasma IGF-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation. Journal of Clinical Endocrinology Metabolism, 71, 688-695.
13. Jørgensen, J.O.L., Möller, N., Lauritzen, T., Alberti, K.G.M.M., Örskov, H. & Christiansen, J.S. (1990) Evening versus morning injections of growth hormone (GH) in GH-deficient patients: Effects on 24-hour patterns of circulating hormones and metabolites. Journal of Clinical Endocrinology Metabolism, 70, 207-214.
14. Kamp, G.A., Kuilboer, M.M., Wynne, H.J., Rongen-Westerlaken, C., Johnson, M.J., Veldhuis, J.D. & Wit, J.-M. (1993) Slow baseline growth and a good response to growth hormone (GH) therapy are related to elevated spontaneous GH pulse frequency in girls with Turner's syndrome. Journal of Clinical Endocrinology Metabolism, 76, 1604-1609.
15. Karlberg, J., Albertsson-Wikland, K., Naeraa, R.W., Rongen-Westerlaken, C. & Wit, J.M. (1993) Reference values for spontaneous growth in Turner girls and its use in estimating treatment effects. In Basic and clinical approach to Turner syndrome (eds I. Hibi & K. Takano), pp. 83-92. Elsevier Science Publishers B.V., Amsterdam.
16. Kratzsch, J., Blum, W.F., Ventz, M., Selisko, T., Birkenmeyer, G. & Keller, E. (1995) Growth hormone-binding protein-related immunoreactivity in the serum of patients with acromegaly is regulated inversely by growth hormone concentration. European Journal Endocrinology, 132, 306-312.
17. Lanes, R., Brito, S., Suniaga, M., Moncada, G. & Borges, M. (1990) Growth hormone secretion in pubertal age patients with Turner's syndrome. Journal of Clinical Endocrinology Metabolism, 71, 770-772.
18. Laursen, T., Jorgensen, J.O.L. & Christiansen, J.S. (1994) Metabolic effects of growth hormone administered subcutaneously once or twice daily to growth hormone deficient adults. Clinical Endocrinology, 41, 337-343.
19. Lenko, H.L. (1979) Prediction of adult height with various methods in Finnish children. Acta Paediatrica Scandinavica, 68, 85-92.
20. Lin, T.H., Kirkland, J.L. & Kirkland, R.T. (1988) Growth hormone assessment and short-term treatment with growth hormone in Turner syndrome. Journal of Pediatrics, 112, 919-922.
21. Marshall, W.A. & Tanner, J.M. (1969) Variations in pattern of pubertal changes in girls. Archives of Disease in Childhood, 44, 291-303.
22. Martha, P.M., Reiter, E.O., Davila, N., Shaw, M.A., Holcombe, J.H. & Baumann, G. (1992) Serum growth hormone (GH)-binding protein/receptor: an important determinant of GH responsiveness. Journal of Clinical Endocrinology Metabolism, 76, 1464-1469.
23. Nienhuis, H.E., Rongen-Westerlaken, C., Wit, J.M., Otten, B.J., de Muinck Keizer-Schrama, S., Drayer, N.M., Delemarre-van de Waal, H.A., Vulsma, T., Oostdijk, W. & Waelkens, J.J.J. (1993) Results of long-term therapy with growth hormone in two dose regimens in Turner syndrome. Hormone Research, 39(Suppl. 2), 31-36.
24. Ranke, M.B., Blum, W.F., Haug, F., Rosendahl, W., Attanasio, A., Enders, H., Gupta, D. & Bierich, J.R. (1987) Growth hormone, somatomedin levels and growth regulation in Turner's syndrome. Acta Endocrinologica (Copenhagen), 116, 305-313.
25. Ranke, M.B., Frisch, H., Blum, W.F., Wollmann, H. & Bruegmann, G. (1993) Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) during treatment with growth hormone in Ullrich-Turner syndrome. In Basic and clinical approach to Turner syndrome (eds I. Hibi & K. Takano), pp. 239-244. Elsevier Science Publishers B.V., Amsterdam.
26. Roede, M.J. & Van Wieringen, J.C. (1985) Growth diagrams 1980. Netherlands third nationwide survey. Tijdschrift voor Sociale Gezondheidszorg, 63(Suppl.), 1-34.
27. Rolland-Cachera, M.F., Sempe, M., Guilloud-Bataille, M., Patois, E., Pequignot-Guggenbuhl, F. & Fautrad, V. (1982) Adiposity indices in children. American Journal of Clinical Nutrition, 78, 178-184.
28. Rongen-Westerlaken, C. & Wit, J.M. (1991) Growth hormone therapy in Turner syndrome: the Dutch experience. In Turner syndrome: Growth promoting therapies (eds M.B. Ranke & R. Rosenfeld), pp. 225-229. Elsevier Science Publishers B.V. (Biomedical Division), Amsterdam.
29. Ross, J.L., Long, L.M., Loriaux, D.L. & Cutler, G.B.J. (1985) Growth hormone secretory dynamics in Turner syndrome. Journal of Pediatrics, 106, 202-206.
30. Saggese, G., Federico, G. & Cinquanta, L. (1995) Plasma growth hormone-binding protein activity. Insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration. Pediatric Research, 37, 106-111.
31. Smith, P.J., Pringle, P.J. & Brook, C.G.D. (1987) Single dose and pulsatile treatment with human growth hormone in growth hormone deficiency. Archives of Disease in Childhood, 62, 849-851.
32. Smith, P.J., Hindmarsh, P.C. & Brook, C.G.D. (1988) Contribution of dose and frequency of administration to the therapeutic effect of growth hormone. Archives of Disease in Childhood, 63, 491-494.
33. Tanner, J.M. (1962) Growth at Adolescence. Blackwell Science Ltd, Oxford.
34. Tanner, J.M., Whitehouse, R.H., Cameron, N., Marshall, W.A., Healy, M.J.R. & Goldstein, H. (1983) Assessment of skeletal maturity and prediction of adult height (TW2-method). Academic Press, London.
35. Tanner, J.M. & Whitehouse, R.H. (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Archives of Disease in Childhood, 51, 170-179.
36. Van Es, A., Massarano, A.A., Wit, J.M., Hindmarsh, P.C., Kamp, G.A., Brook, C.G.D., Preece, M.A. & Matthews, D.R. (1991) 24-Hour growth hormone secretion in Turner syndrome. In Turner syndrome: Growth promoting therapies (eds M.B. Ranke & R. Rosenfeld), pp. 29-33. Elsevier Science Publishers B.V. (Biomedical Division), Amsterdam.
37. Van Teunenbroek, A., de Muinck Keizer-Schrama, S.M.P.F., Stijnen, T., Mouton, J.W., Blum, W.F., Mercado, M., Baumann, G., Drop, S.L.S. & the Dutch Working Group on Growth Hormone (1993) Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Clinical Endocrinology, 39, 77-84.
38. Van Teunenbroek, A., Stijnen, T., Otten, B., de Muinck Keizer-Schrama, S.M.P.F., Naeraa, R.W., Rongen-Westerlaken, C. & Drop, S.L.S. (1996a) A regression method including chronological and bone age for predicting final height in Turner syndrome, with a comparison of existing methods. Acta Paediatrics, 65, 413-420.
39. Van Teunenbroek, A., de Waal, W., Roks, A., Chinafo, P., Fokker, M., Mulder, P., de Muinck Keizer-Schrama, S. & Drop, S. (1996b) Computer Aided Skeletal Age Scores (CASAS) in healthy children, girls with Turner syndrome, and in children with constitutionally tall stature. Pediatric Research, 39, 360-367.
40. Wit, J.M., Massarano, A.A., Kamp, G.A., Hindmarsh, P.C., van Es, A., Brook, C.G.D., Preece, M.A. & Matthews, D.R. (1992) Growth hormone (GH) secretion in Turner girls as determined by time series analysis. Acta Endocrinologica, 127, 7-12.